Citations

Showing 10 of 108119 citations.

Impact of Fenfluramine on the Expected SUDEP Incidence Rate in Patients with Dravet Syndrome
Pringsheim, M., Cross, J. Helen , Galer, B. S., Lagae, Lieven , Donner, Elizabeth , Gammaitoni, Arnold R. , Cross, Helen J , Gil‐Nagel, António , Devinsky, Orrin , Ceulemans, Berten , Schoonjans, An-Sofie , Wirrell, Elaine

Mayo Clinic

Neuropediatrics | November 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1739610 Get It

Inhibition of Foxo3 during myogenic differentiation
Rodenwaldt, Eyck, Gellhaus, B, Gsaenger, Marlene, Böker, O K, Gellhaus, Benjamin , Kosinsky, Robyn Laura , Schilling, F A, Saul, Dominik

Mayo Clinic

Osteologie | November 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1736723 Get It

A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020
Schuster, Jennifer E. , Halasa, Natasha , Nakamura, Mari , Levy, Emily R. , Young, Cameron C. , Newhams, Margaret M. , Bourgeois, Florence T. , Staat, Mary Allen , Hobbs, Charlotte V. , Feldstein, Leora R. , Jackson, A. , Mack, Elizabeth H. , Walker, Tracie C. , Spinella, Philip C. , Loftis, Laura L. , Kong, Michele , Rowan, Courtney M. , McLaughlin, Gwenn E., Hall, Mark W. , Babbitt, Christopher , Maamari, Mia , Zinter, Matt S. , Gertz, Shira J. , Carroll, Christopher L. , Singh, Aalok R. , Hymes, Saul , Schwarz, Adam J. , McGuire, John K. , Nofziger, Ryan A. , Flori, Heidi R. , Clouser, Katharine N. , Wellnitz, Kari , Cullimore, Melissa L. , Hume, Janet R. , Patel, Manish , Randolph, Adrienne G. , Investigators, Overcoming COVID-19, Patel, Manish R. , Feldstein, Leora R , Levy, Emily R , Young, Cameron C , Randolph, Adrienne G , Spinella, Philip C , Kong, Michele , Hume, Janet R , Hobbs, Charlotte V , Staat, Mary A , Gertz, Shira J , Hymes, Saul R , Fitzgerald, Julie C. , Dapul, Heda , Jackson, Ashley M, Maddux, Aline B. , Bembea, Melania M. , Cvijanovich, Natalie Z , Michelson, Kelly Nicole , Thomas, Neal J. , Giuliano, John S. , Investigators, Overcoming COVID-19

Mayo Clinic

Journal of the Pediatric Infectious Diseases Society | November 17, 2021 | Volume: 11 | Issue: 5 | Pages: 191-198

10.1093/jpids/piab123 | PMID 35022779 Get It

Abstract Background It is unclear how acute coronavirus disease 2019 (COVID-19)-directed therapies are used in children with life-threatening COVID-19 in US hospitals. We described characteristics of children hospitalized in the intensive care unit or step-down unit (ICU/SDU) who received COVID-19-directed therapies and the specific therapies administered. Methods Between March 15, 2020 and December 27, 2020, children <18 years of age in the ICU/SDU with acute COVID-19 at 48 pediatric hospitals in the United States were identified. Demographics, laboratory values, and clinical course were compared in children who did and did not receive COVID-19-directed therapies. Trends in COVID-19-directed therapies over time were evaluated. Results Of 424 children in the ICU/SDU, 235 (55%) received COVID-19-directed therapies. Children who received COVID-19-directed therapies were older than those who did not receive COVID-19-directed therapies (13.3 [5.6-16.2] vs 9.8 [0.65-15.9] years), more had underlying medical conditions (188 [80%] vs 104 [55%]; difference = 25% [95% CI: 16% to 34%]), more received respiratory support (206 [88%] vs 71 [38%]; difference = 50% [95% CI: 34% to 56%]), and more died (8 [3.4%] vs 0). Of the 235 children receiving COVID-19-directed therapies, 172 (73%) received systemic steroids and 150 (64%) received remdesivir, with rising remdesivir use over the study period (14% in March/April to 57% November/December). Conclusion Despite the lack of pediatric data evaluating treatments for COVID-19 in critically ill children, more than half of children requiring intensive or high acuity care received COVID-19-directed therapies.
All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis
Chaudhary, Haseeb , Bohra, Nidrit , Syed, Khezar , Donato, Anthony A. , Karmacharya, Paras , Karmacharya, Paras , Donato, Anthony , Murad, M. Hassan

Mayo Clinic

Arthritis Care & Research | November 17, 2021 | Volume: 75 | Issue: 5 | Pages: 1052-1065

10.1002/acr.24820 | PMID 34788902 Get It

ObjectivePsoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory diseases associated with a higher risk of cardiometabolic comorbidities compared to the general population. Individual studies examining mortality in these patients have produced conflicting results. The present study was undertaken to perform a systematic review and meta‐analysis to analyze the all‐cause and cause‐specific mortality in PsA and AS from the available literature.MethodsA comprehensive database search was performed for studies reporting all‐cause or cause‐specific mortality in patients with PsA and AS compared with the general population. Pooled relative risks (RRs) were calculated using a random‐effects model.ResultsWe included 19 studies (11 of PsA, 7 of AS, 1 of both). In PsA studies, there was no increased mortality compared to the general population (RR 1.12 [95% confidence interval (95% CI) 0.96–1.30]; n = 10 studies). We found a higher all‐cause mortality in female (RR 1.19 [95% CI 1.04–1.36]) but not in male (RR 1.02 [95% CI 0.66–1.59]) PsA patients. Cardiovascular‐, respiratory‐, and infection‐specific mortality risks were significantly higher for PsA patients (RR 1.21 [95% CI 1.06–1.38], RR 3.37 [95% CI 1.30–8.72], and RR 2.43 [95% CI 1.01–5.84], respectively), but not cancer‐related mortality (RR 1.01 [95% CI 0.91–1.11]). In AS, we found a higher risk of death from all causes (RR 1.64 [95% CI 1.49–1.80]; n = 6 studies) and cardiovascular causes (RR 1.35 [95% CI 1.01–1.81]; n = 3 studies) compared to the general population. All‐cause mortality was high in both male (RR 1.56 [95% CI 1.43–1.71]) and female (RR 1.85 [95% CI 1.56–2.18]) AS patients. The included AS studies did not report mortality data for non‐cardiovascular causes.ConclusionThis systematic review and meta‐analysis showed a significantly increased risk of overall mortality in AS but not PsA. Cardiovascular‐specific mortality was higher for both PsA and AS, which emphasizes the importance of early screening and management of cardiovascular risk factors.
Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19
Subat, Yosuf W., Hainy, Matthew E, Torgerud, Keith D, Sajgalik, Pavol , Guntupalli, Siva Kamal, Johnson, Bruce D. , Kim, Chul‐Ho , Scanlon, Paul D., Chul-Ho, Kim, Lim, Kaiser G. , Helgeson, Scott A. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | November 17, 2021 | Volume: 66 | Issue: 12 | Pages: 1858-1865

10.4187/respcare.09236 | PMID 34789516 Get It

BACKGROUND: Methacholine bronchoprovocation or challenge testing (MCT) is commonly performed to assess airway hyper-responsiveness in the setting of suspected asthma. Nebulization is an aerosol-generating procedure, but little is known about the risks of MCT in the context of the ongoing coronavirus disease 2019 (COVID-19) pandemic. We aimed to quantify and characterize aerosol generation during MCT by using different delivery methods and to assess the impact of adding a viral filter. METHODS: Seven healthy subjects performed simulated MCT in a near particle-free laboratory space with 4 different nebulizers and with a dosimeter. Two devices continuously sampled the ambient air during the procedure, which detected ultrafine particles, from 0.02–1 μm, and particles of sizes 0.3, 0.5, 1.0, 2.0, 5.0, and 10 µm, respectively. Particle generation was compared among all the devices, with and without viral filter placement. RESULTS: Ultrafine-particle generation during simulated MCT was significant across all the devices. Ultrafine-particle (0.02–1 μm) concentrations decreased 77%–91% with the addition of a viral filter and varied significantly between unfiltered (P < .001) and filtered devices (P < .001). Ultrafine-particle generation was lowest when using the dosimeter with filtered Hudson nebulizer (1,258 ± 1,644 particle/mL). Ultrafine-particle concentrations with the filtered nebulizer devices using a compressor were higher than particle concentrations detected when using the dosimeter: Monaghan (3,472 ± 1,794 particles/mL), PARI (4,403 ± 2,948), Hudson (6,320 ± 1,787) and AirLife (9,523 ± 5,098). CONCLUSIONS: The high particle concentrations generated during MCT pose significant infection control concerns during the COVID-19 pandemic. Particle generation during MCT was significantly reduced by using breath-actuated delivery and a viral filter, which offers an effective mitigation strategy.
Influence of Menopausal Hormone Therapy on the Breast: Counseling Your Patients Before You Prescribe
Lester, Sara P., Vegunta, Suneela

Mayo Clinic

Journal of Women's Health | November 17, 2021 | Volume: 31 | Issue: 2 | Pages: 167-170

10.1089/jwh.2021.0322 | PMID 34788572 Get It

Menopausal hormone therapy (HT) aims to improve a woman's quality of life by treating bothersome menopausal symptoms associated with low estrogen levels. Although HT is prescribed to millions of women worldwide, its breast-related adverse effects have always been a concern. Some of the common adverse effects of HT are breast fullness, increased breast density, and increased breast cancer (BC) risk. Health care professionals need to be aware of the influence of HT on breast tissue to provide appropriate counseling as part of informed decision making. Our review summarizes the influence of HT on breast symptoms, breast density, mammograms, and BC risk.
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
Brieger, Katharine K. , Phung, Minh Tung , Mukherjee, Bhramar, Bakulski, Kelly M. , Anton-Culver, Hoda, Bandera, Elisa V. , Bowtell, David D.L., Cramer, Daniel W., DeFazio, Anna , Doherty, Jennifer A. , Fereday, Sian, Fortner, Renée T. , Goode, Ellen L., Goodman, Marc T., Menon, Usha , Moysich, Kirsten B., Qin, Bo , Ramus, Susan J. , Risch, Harvey A., Rossing, Mary Anne, Schildkraut, Joellen M., Trabert, Britton , Wentzensen, Nicolas, Wu, Anna H., Khoja, Lilah , Richardson, Jean , Grout, Bronwyn, Chase, Anne, Deurloo, Cindy McKinnon, Odunsi, Kunle , Brenton, James D. , Terry, Kathryn L., Pharoah, Paul D.P., Berchuck, Andrew, Hanley, Gillian E., Pike, Malcolm C. , Pearce, Celeste Leigh, Goodman, Marc T. , Terry, Kathryn L. , Bowtell, David D.L. , Fereday, Sián , Hanley, Gillian E. , Fortner, Renée T , Gentry‐Maharaj, Aleksandra , Harris, Holly R , Matsuo, Keitaro , Menon, Usha , Modugno, Francesmary , Qin, Bo , Ramus, Susan J , Trabert, B , Vierkant, Robert A , Winham, Stacey J , Ziogas, Argyrios , Khoja, Lilah , Cho, Kathleen R , McLean, Karen , Richardson, Jean , Odunsi, Kunle , Nelson, Brad H , Brenton, James D , Webb, Penelope M , Pike, Malcolm C , Fazio, Anna de , Doherty, Jennifer A , Moysich, Kirsten , Bowtell, David D , Fereday, Sian , Goodman, Marc T , Brieger, Katharine K. , Phung, Minh Tung , Mukherjee, Bhramar, Bakulski, Kelly M. , Anton-Culver, Hoda, Bandera, Elisa V. , Cramer, Daniel W., Goode, Ellen L., Goodman, Marc T., Moysich, Kirsten B. , Risch, Harvey A., Rossing, Mary Anne, Schildkraut, Joellen M., Wentzensen, Nicolas, Wu, Anna H., Grout, Bronwyn, Chase, Anne, Deurloo, Cindy McKinnon, Pharoah, Paul D.P., Berchuck, Andrew, Pearce, Celeste Leigh

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 17, 2021 | Volume: 31 | Issue: 2 | Pages: 443-452

10.1158/1055-9965.epi-21-0977 | PMID 34789471 Get It

Abstract Background: There is suggestive evidence that inflammation is related to ovarian cancer survival. However, more research is needed to identify inflammation-related factors that are associated with ovarian cancer survival and to determine their combined effects. Methods: This analysis used pooled data on 8,147 women with invasive epithelial ovarian cancer from the Ovarian Cancer Association Consortium. The prediagnosis inflammation-related exposures of interest included alcohol use; aspirin use; other nonsteroidal anti-inflammatory drug use; body mass index; environmental tobacco smoke exposure; history of pelvic inflammatory disease, polycystic ovarian syndrome, and endometriosis; menopausal hormone therapy use; physical inactivity; smoking status; and talc use. Using Cox proportional hazards models, the relationship between each exposure and survival was assessed in 50% of the data. A weighted inflammation-related risk score (IRRS) was developed, and its association with survival was assessed using Cox proportional hazards models in the remaining 50% of the data. Results: There was a statistically significant trend of increasing risk of death per quartile of the IRRS [HR = 1.09; 95% confidence interval (CI), 1.03–1.14]. Women in the upper quartile of the IRRS had a 31% higher death rate compared with the lowest quartile (95% CI, 1.11–1.54). Conclusions: A higher prediagnosis IRRS was associated with an increased mortality risk after an ovarian cancer diagnosis. Further investigation is warranted to evaluate whether postdiagnosis exposures are also associated with survival. Impact: Given that pre- and postdiagnosis exposures are often correlated and many are modifiable, our study results can ultimately motivate the development of behavioral recommendations to enhance survival among patients with ovarian cancer.
Esophageal carcinoma in achalasia patients managed with endoscopic submucosal dissection and peroral endoscopic myotomy: Japan Achalasia Multicenter Study
Sato, Hiroki , Nishikawa, Yohei , Shiwaku, Hironari , Shiota, Junya , Sakae, Hiroyuki , Ominami, Masaki , Hata, Yoshitaka , Fukuda, Hisashi , Ogawa, Ryo , Tatsuta, Tetsuya , Yokomichi, Hiroshi , Terai, Shuji , Inoue, Haruhiro , Sakae, Hiroyuki , Abe, Hirofumi , Sato, Chiaki , Nakamura, Jun , Ikebuchi, Yuichiro

Mayo Clinic

Digestive Endoscopy | November 17, 2021 | Volume: 34 | Issue: 5 | Pages: 965-973

10.1111/den.14197 | PMID 34787940 Get It

ObjectivesIndications for peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) in patients with achalasia concomitant with esophageal carcinoma (EC) are unclear. This study aimed to clarify the role of POEM in cases of achalasia concomitant with EC and to elucidate the indications for ESD and efficient surveillance for EC.MethodsWe conducted a multicenter cohort study at 14 hospitals in Japan, including 3707 cases of achalasia‐related esophageal motility disorders (EMDs). Factors contributing to EC risk, the characteristics of EC, and clinical outcomes of POEM/ESD were analyzed.ResultsIn patients undergoing POEM, screening and surveillance endoscopy throughout a 1‐year period resulted in diagnosis of 72.1% new EC cases. Of 62 patients with 123 ECs, 40.3% had multiple or metachronous lesions within 37.5 months. EC was predominantly observed in the middle thoracic esophagus (58.5%) and posteriorly (73.2%). POEM had comparable safety and efficacy in cases of concomitant EC even after ESD. Endoscopic en bloc resection was performed in 95.8% and 89.3% of ECs diagnosed before and after POEM, respectively (P = 0.351); however, ESD on the POEM‐line was impaired by fibrosis. Multivariate analysis revealed risk factors for EC, including regular alcohol consumption, a history of smoking, advanced age, and extended disease duration. Alcohol intake and smoking had a synergistic effect on EC development.ConclusionsScreening and surveillance of POEM help in detecting EC. ESD is feasible in achalasia, although on the POEM‐line is challenging. Surveillance endoscopy for EC is recommended for cases with specific risks and a history of ECs.
The Effect of the COVID-19 Pandemic on Pulmonary Diagnostic Procedures
Call, Justin T. , Lee, Augustine S. , Helgeson, Scott A. , Helgeson, Scott A , Haendel, Melissa , Chute, Christopher G.

Mayo Clinic

Annals of the American Thoracic Society | November 17, 2021 | Volume: 19 | Issue: 4 | Pages: 695-697

10.1513/annalsats.202108-943rl | PMID 34788203 Get It